Brief Reports
Vol. 5 No. 1 (2026)
Cardiovascular risk profile evolution over 15 years: comparison between CV-PREVITAL Trial and Moli-sani Study participants
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 15 January 2026
395
Views
84
Downloads
Authors
Fifteen years elapsed between two surveys of cardiovascular (CV) risk factors in the same Italian region. Modifiable CV risk profiles were compared among 2,199 individuals enrolled in the CV-PREVITAL trial (2022-2024) at IRCCS Neuromed with those of 16,656 participants from the Moli-sani Study (2005-2010), matched for age and absence of prior CV disease. The Moli-sani Risk Score is a validated algorithm incorporating nine common modifiable risk factors measured overall risk. Most individual risk factors were more favorable in CV-PREVITAL compared with Moli-sani participants, besides hypertension in men and glucose levels in women. Relative fat mass was similar in both cohorts. Men in CV-PREVITAL had a mean Moli-sani Risk Score 4.8 points lower than Moli-sani men; women showed a 4.5-point reduction. These findings suggest a meaningful decline in modifiable CV risk over a 15-year interval, potentially reflecting enhanced prevention awareness, improved therapeutic efficacy, and cumulative effects of long-term public health communication.
Downloads
Download data is not yet available.
Citations
1. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction. Circulation 2010;121:586-613. DOI: https://doi.org/10.1161/CIRCULATIONAHA.109.192703
2. Iacoviello L, Donati MB. Unveiling the “common soil” of cardiovascular disease and cancer. Bleeding Thromb Vasc Biol 2025;4:167. DOI: https://doi.org/10.4081/btvb.2025.167
3. Global Cardiovascular Risk Consortium, Magnussen C, Ojeda FM, et al. Global effect of modifiable risk factors on cardiovascular disease and mortality. N Engl J Med 2023;389:1273–85. DOI: https://doi.org/10.1056/NEJMoa2206916
4. Di Castelnuovo A, Costanzo S, Persichillo M, et al. Distribution of short and lifetime risks for cardiovascular disease in Italians. Eur J Prev Cardiol 2012;19:723-30. DOI: https://doi.org/10.1177/1741826711410820
5. Di Castelnuovo A, Bonaccio M, Costanzo S, et al. The Moli-sani risk score, a new algorithm for measuring the global impact of modifiable cardiovascular risk factors. Int J Cardiol 2023;389:131228. DOI: https://doi.org/10.1016/j.ijcard.2023.131228
6. Baldassarre D, Iacoviello L, Baetta R, et al. Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention. BMJ Open 2023;13:e072040. DOI: https://doi.org/10.1136/bmjopen-2023-072040
7. Vasan RS, Enserro DM, Xanthakis V, et al. Temporal trends in the remaining lifetime risk of cardiovascular disease among middle-aged adults across 6 decades: The Framingham Study. Circulation 2022;145:1324-38. DOI: https://doi.org/10.1161/CIRCULATIONAHA.121.057889
8. Pisani P. Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres. Int J Epidemiol 1997;26:152S-60. DOI: https://doi.org/10.1093/ije/26.suppl_1.S152
9. Bonaccio M, Costanzo S, Di Castelnuovo A, et al. The CASSIOPEA Study (Economic Crisis and Adherence to the Mediterranean diet: poSSIble impact on biOmarkers of inflammation and metabolic PhEnotypes in the cohort of the Moli-sAni Study): Rationale, design and characteristics of participants. Nutr Metabol Cardiovasc Dis 2021;31:1053-62. DOI: https://doi.org/10.1016/j.numecd.2020.12.008
10. Ghulam A, Gianfagna F, Bonaccio M, et al. Association between BMI, RFM and mortality and potential mediators: Prospective findings from the Moli-sani study. Int J Obes 2023;47:697-708. DOI: https://doi.org/10.1038/s41366-023-01313-5
11. Gao Y, Isakadze N, Duffy E, et al. Secular trends in risk profiles among adults with cardiovascular disease in the United States. J Am Coll Cardiol2022;80:126–37. DOI: https://doi.org/10.1016/j.jacc.2022.04.047
12. Bafunno D, Catino A, Lamorgese V, et al. Impact of tobacco control interventions on smoking initiation, cessation, and prevalence: a systematic review. J Thorac Dis 2020;12:3844–56. DOI: https://doi.org/10.21037/jtd.2020.02.23
13. Lin PD, Rifas‐Shiman S, Merriman J, et al. Trends of antihypertensive prescription among US adults From 2010 to 2019 and changes following treatment guidelines: analysis of multicenter electronic health records. J Am Heart Assoc 2024;13:e032197. DOI: https://doi.org/10.1161/JAHA.123.032197
14. Berteotti M, Ageno W, Marcucci R, et al. The role of dyslipidemia and gender-related risk factors in the management of patients with abdominal aortic aneurysms: a survey from the Italian Society of Angiology and Vascular Medicine and a call to action. Bleeding Thromb Vasc Biol 2025;4:164. DOI: https://doi.org/10.4081/btvb.2025.164
15. Gao Y, Shah LM, Ding J, Martin SS. US Trends in cholesterol screening, lipid levels, and lipid‐lowering medication use in US adults, 1999 to 2018. J Am Heart Assoc 2023;12:e028205. DOI: https://doi.org/10.1161/JAHA.122.028205
16. Boujelbane MA, Ammar A, Salem A, et al. Gender-specific insights into adherence to Mediterranean diet and lifestyle: analysis of 4,000 responses from the MEDIET4ALL project. Front Nutr 2025;12:570904. DOI: https://doi.org/10.3389/fnut.2025.1570904
17. Poulimeneas D, Anastasiou CA, Santos I, et al. Exploring the relationship between the Mediterranean diet and weight loss maintenance: the MedWeight study. Br J Nutr 2020;124:874-80. DOI: https://doi.org/10.1017/S0007114520001798
18. Bonaccio M, Di Castelnuovo A, Costanzo S, et al. Combination of a traditional Mediterranean Diet with ultra-processed food consumption in relation to all-cause and cause-specific mortality: Prospective findings from the Moli-sani Study. Clin Nutr 2025;50:83-91. DOI: https://doi.org/10.1016/j.clnu.2025.04.024
19. Persichillo M, Bracone F, De Curtis A et al. Comparison of cardiovascular risk profiles between subjects enrolled in the CV-PREVITAL trial or in the Moli-sani study: a 15-year comparative analysis. Proc. 28th SISET National Congress, Rome. Bleeding Thromb Vasc Biol 2024; p. 60.
How to Cite
1.
Di Castelnuovo A, Persichillo M. Cardiovascular risk profile evolution over 15 years: comparison between CV-PREVITAL Trial and Moli-sani Study participants. Bleeding Thromb Vascul Biol [Internet]. 2026 Jan. 15 [cited 2026 Feb. 15];5(1). Available from: https://www.btvb.org/btvb/article/view/416
Copyright (c) 2026 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
